z-logo
Premium
A Modified Grapefruit Juice Eliminates Two Compound Classes as Major Mediators of the Grapefruit Juice–Fexofenadine Interaction: An In Vitro–In Vivo “Connect”
Author(s) -
Won Christina S.,
Lan Tian,
VanderMolen Karen M.,
Dawson Paul A.,
Oberlies Nicholas H.,
Widmer Wilbur W.,
Scarlett Yolanda V.,
Paine Mary F.
Publication year - 2013
Publication title -
the journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.92
H-Index - 116
eISSN - 1552-4604
pISSN - 0091-2700
DOI - 10.1002/jcph.136
Subject(s) - grapefruit juice , fexofenadine , terfenadine , chemistry , organic anion transporting polypeptide , pharmacology , citrus paradisi , naringin , pharmacokinetics , crossover study , bioavailability , food science , in vivo , chromatography , biochemistry , transporter , medicine , microbiology and biotechnology , biology , alternative medicine , pathology , rutaceae , horticulture , gene , placebo
The grapefruit juice (GFJ)–fexofenadine interaction involves inhibition of intestinal organic anion transporting polypeptide (OATP)‐mediated uptake. Only naringin has been shown clinically to inhibit intestinal OATP; other constituents have not been evaluated. The effects of a modified GFJ devoid of furanocoumarins (∼99%) and polymethoxyflavones (∼90%) on fexofenadine disposition were compared to effects of the original juice. Extracts of both juices inhibited estrone 3‐sulfate and fexofenadine uptake by similar extents in OATP‐transfected cells (∼50% and ∼25%, respectively). Healthy volunteers (n = 18) were administered fexofenadine (120 mg) with water, GFJ, or modified GFJ (240 mL) by randomized, three‐way crossover design. Compared to water, both juices decreased fexofenadine geometric mean AUC and C max by ∼25% ( P  ≤ .008 and P  ≤ .011, respectively), with no effect on terminal half‐life ( P  = .11). Similar effects by both juices on fexofenadine pharmacokinetics indicate furanocoumarins and polymethoxyflavones are not major mediators of the GFJ–fexofenadine interaction.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here